Efficacy of pregabalin in the treatment of trigeminal neuralgia |
| |
Authors: | Obermann M Yoon M S Sensen K Maschke M Diener H C Katsarava Z |
| |
Institution: | Department of Neurology, University of Duisburg-Essen, Essen and;Department of Neurology and Neurophysiology, Bruederkrankenhaus Trier, Germany |
| |
Abstract: | This prospective, open-label study aimed to evaluate the efficacy of pregabalin treatment in patients suffering from trigeminal neuralgia with and without concomitant facial pain. Fifty-three patients with trigeminal neuralgia (14 with concomitant chronic facial pain) received pregabalin (PGB) 150–600 mg daily and were prospectively followed for 1 year. The primary outcome was number of patients pain free or with reduction of pain intensity by > 50% and of attack frequency by > 50% after 8 weeks. Secondary outcome was sustained pain relief after 1 year. Thirty-nine patients (74%) improved after 8 weeks with a mean dose of 269.8 mg/day (range 150–600 mg/day) PGB: 13 (25%) experienced complete pain relief and 26 (49%) reported pain reduction > 50%, whereas 14 (26%) did not improve. Patients without concomitant facial pain showed better response rates (32 of 39, 82%) compared with patients with concomitant chronic facial pain (7 of 14, 50%, P = 0.020). Concomitant chronic facial pain appears to be a clinical predictor of poor treatment outcome. PGB appears to be effective in the treatment of trigeminal neuralgia. |
| |
Keywords: | Facial pain neuropathic pain pregabalin treatment trigeminal neuralgia |
本文献已被 PubMed 等数据库收录! |
|